CMS issues guidance on IMD treatment option for substance use disorders
![mental-health-awareness-week](/sites/default/files/styles/900x400/public/2018-10/mental-health-awareness-week.jpg?itok=pjDCd-Lt)
The Centers for Medicare & Medicaid Services yesterday released guidance for state Medicaid agencies implementing Section 5052 of the SUPPORT for Patients and Communities Act of 2018, which gives states the option to cover substance use disorder treatment and withdrawal management services for adults who reside primarily in an eligible institution for mental diseases. The guidance provides information on the new state plan option, including requirements related to beneficiary and provider eligibility, clinical screenings, continuum of care, care transitions, and maintenance of existing expenditures.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services Aug. 15 released a state funding notice for the Cell and Gene Therapy Access Model. The CGT Access Model will…
Headline
Mary Thompson — a member of AHA’s Committee on Behavioral Health and president of Trillium Place, a mental health and addiction recovery organization…
Blog
More than 16 years ago, the U.S. House of Representatives designated July as National Minority Mental Health Awareness Month. Inspired by the work of author…
Perspective
It’s an understatement to say everything on the national political scene is both unprecedented and unpredictable these days.To state the obvious, there will be…
Headline
The AHA July 25 urged the Centers for Medicare & Medicaid Services to maintain the uninsured rate at 8.7% under the inpatient prospective payment system…
Headline
The Substance Abuse and Mental Health Services Administration July 24 announced it is awarding $45.1 million in grants toward various behavioral health…